Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
<p>Figure S2. Lurbinectedin sensitivity (IC50) correlation with MYC expression and changes in expression of NE markers.</p>
Kaydedildi:
| Yazar: | |
|---|---|
| Diğer Yazarlar: | , , , , , , , |
| Baskı/Yayın Bilgisi: |
2025
|
| Konular: | |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
| _version_ | 1849927632776331264 |
|---|---|
| author | Subhamoy Chakraborty (16648124) |
| author2 | Charles Coleman (16648127) Parvathy Manoj (16648130) Deniz Demircioglu (15306139) Nisargbhai Shah (16648133) Elisa de Stanchina (14954757) Charles M. Rudin (11572933) Dan Hasson (15306151) Triparna Sen (14126577) |
| author2_role | author author author author author author author author |
| author_facet | Subhamoy Chakraborty (16648124) Charles Coleman (16648127) Parvathy Manoj (16648130) Deniz Demircioglu (15306139) Nisargbhai Shah (16648133) Elisa de Stanchina (14954757) Charles M. Rudin (11572933) Dan Hasson (15306151) Triparna Sen (14126577) |
| author_role | author |
| dc.creator.none.fl_str_mv | Subhamoy Chakraborty (16648124) Charles Coleman (16648127) Parvathy Manoj (16648130) Deniz Demircioglu (15306139) Nisargbhai Shah (16648133) Elisa de Stanchina (14954757) Charles M. Rudin (11572933) Dan Hasson (15306151) Triparna Sen (14126577) |
| dc.date.none.fl_str_mv | 2025-11-25T13:22:15Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30708495 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/figure/Figure_S2_from_i_De_Novo_i_and_Histologically_Transformed_Small-Cell_Lung_Cancer_Is_Sensitive_to_Lurbinectedin_Treatment_Through_the_Modulation_of_EMT_and_NOTCH_Signaling_Pathways/30708495 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Cancer Detection and Diagnosis Methods and Technology Biomarkers Lung Cancer Preclinical Models |
| dc.title.none.fl_str_mv | Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways |
| dc.type.none.fl_str_mv | Image Figure info:eu-repo/semantics/publishedVersion image |
| description | <p>Figure S2. Lurbinectedin sensitivity (IC50) correlation with MYC expression and changes in expression of NE markers.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_5977b7fb3ed762b6ee0b5e5dedfa666d |
| identifier_str_mv | 10.1158/1078-0432.30708495 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30708495 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling PathwaysSubhamoy Chakraborty (16648124)Charles Coleman (16648127)Parvathy Manoj (16648130)Deniz Demircioglu (15306139)Nisargbhai Shah (16648133)Elisa de Stanchina (14954757)Charles M. Rudin (11572933)Dan Hasson (15306151)Triparna Sen (14126577)CancerCancer Detection and DiagnosisMethods and TechnologyBiomarkersLung CancerPreclinical Models<p>Figure S2. Lurbinectedin sensitivity (IC50) correlation with MYC expression and changes in expression of NE markers.</p>2025-11-25T13:22:15ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30708495https://figshare.com/articles/figure/Figure_S2_from_i_De_Novo_i_and_Histologically_Transformed_Small-Cell_Lung_Cancer_Is_Sensitive_to_Lurbinectedin_Treatment_Through_the_Modulation_of_EMT_and_NOTCH_Signaling_Pathways/30708495CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307084952025-11-25T13:22:15Z |
| spellingShingle | Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways Subhamoy Chakraborty (16648124) Cancer Cancer Detection and Diagnosis Methods and Technology Biomarkers Lung Cancer Preclinical Models |
| status_str | publishedVersion |
| title | Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways |
| title_full | Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways |
| title_fullStr | Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways |
| title_full_unstemmed | Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways |
| title_short | Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways |
| title_sort | Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways |
| topic | Cancer Cancer Detection and Diagnosis Methods and Technology Biomarkers Lung Cancer Preclinical Models |